Pharmaceutical Analysis & Statistics, January 2015 (p4)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

91-140 of about 20 000 reports

Purchase Reports From Reputable Market Research Publishers

2015 Market Research Report on Global Diabetes Drugs Industry

2015 Market Research Report on Global Diabetes Drugs Industry

  • $ 3 600
  • Industry report
  • January 2015
  • by QY Research Group

Summary 2015 Market Research Report on Global Diabetes Drugs Industry is a professional and depth research report on Global Diabetes Drugs industry For overview analysis, the report introduces Diabetes ...

  • Industries : Drug and Medication
  • Countries : World
2014 Market Research Report on Global Venlafaxine Industry

2014 Market Research Report on Global Venlafaxine Industry

  • $ 3 600
  • Industry report
  • December 2014
  • by QY Research Group

Summary 2014 Market Research Report on Global Venlafaxine Industry is a professional and depth research report on Global Venlafaxine industry For overview analysis, the report introduces Venlafaxine basic ...

  • Industries : Drug and Medication
  • Countries : World
2014 Market Research Report on Global Ibuprofen Industry

2014 Market Research Report on Global Ibuprofen Industry

  • $ 3 600
  • Industry report
  • December 2014
  • by QY Research Group

Summary 2014 Market Research Report on Global Ibuprofen Industry is a professional and depth research report on Global Ibuprofen industry For overview analysis, the report introduces Ibuprofen basic information ...

  • Industries : Over-the-counter Drug
  • Countries : World
Vitamin China E-News 1412

Vitamin China E-News 1412

  • $ 3 564
  • Industry report
  • December 2014
  • by CCM International Limited

Action Plan on Water Pollution Prevention and Control is expected to be introduced in Dec. 201 4. As the national government enhances the water pollution treatment, some domestic vitamins will maintain ...

  • Industries : Vitamin and Supplement
  • Countries : China
Vitamin China E-News 1411

Vitamin China E-News 1411

  • $ 3 564
  • Industry report
  • December 2014
  • by CCM International Limited

A number of domestic vitamin manufacturers released their finanical reports of Q3 in Nov., which showed that many enterprises were confronted with performance decline, like Zhejiang NHU Co., Ltd. whose ...

  • Industries : Vitamin and Supplement
  • Countries : China
Vitamin China E-News 1411

Vitamin China E-News 1411

  • $ 3 564
  • Industry report
  • November 2014
  • by CCM International Limited

With large capacities of vitamins, China is playing a crucial role in the global vitamin industry; In recent years, the fierce competitionamong enterprises seem to transfer from price war to technology. ...

  • Industries : Vitamin and Supplement
  • Countries : China
Vitamins China E-News 1410

Vitamins China E-News 1410

  • $ 3 564
  • Industry report
  • October 2014
  • by CCM International Limited

China is the largest vitamin manufacturer and exporter in the world, playing a critical role in the global vitamin market. Affected by the increasing demand of overseas market, China's VC export volume ...

  • Industries : Vitamin and Supplement
  • Countries : China
Patent Cliff and the Future of Generics in Asia : Trends that will Impact the Market in the Short Term

Patent Cliff and the Future of Generics in Asia : Trends that will Impact the Market in the Short Term

  • $ 3 500
  • Industry report
  • December 2014
  • by Frost & Sullivan

Executive Summary •The generic drug manufacturers in Asia have started looking beyond patent cliff to drive growth. As less drugs are expected to go off patent in 2015-2017, the manufacturers are adopting ...

  • Industries : Generic Drug
Global Bio Stimulants in Turf and ornamentals Market

Global Bio Stimulants in Turf and ornamentals Market

  • $ 3 500
  • Industry report
  • December 2014
  • by Micro Market Monitor

Bio stimulants are used in turf and ornamentals to enhance root growth in turf. Using it, turf and ornamentals appear healthy and strong, thereby increasing bio stimulant usage from last few years. The ...

  • Industries : Drug and Medication
  • Countries : World
Global Transdermal Drug Delivery Market to 2017: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation

Global Transdermal Drug Delivery Market to 2017: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation

  • $ 3 500
  • Industry report
  • December 2014
  • by Kelly Scientific Publications

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 320 tables & figures ...

  • Industries : Drug Delivery Technology
  • Countries : World
Global Biologic Therapeutics Market 2014-2018

Global Biologic Therapeutics Market 2014-2018

  • $ 3 500
  • Industry report
  • October 2014
  • by Infiniti Research Limited

About Biologic Therapeutics Biologic therapeutics include virus, therapeutic serum, toxin, allergenic product, antitoxin, blood component or derivative, vaccine, blood, protein (except any chemically synthesized ...

  • Industries : Therapy
  • Countries : World
Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023

Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Avastin (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China, United States, United Kingdom, Europe
Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023

Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Erbitux (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China, United States, United Kingdom, Europe
Vectibix (Colorectal Cancer) - Forecast and Market Analysis to 2023

Vectibix (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Vectibix (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Vectibix (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China, United States, United Kingdom, Europe
Stivarga (Colorectal Cancer) - Forecast and Market Analysis to 2023

Stivarga (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Stivarga (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Stivarga (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : Japan, World, Spain, Italy, France, Germany, China, Europe, United States, United Kingdom
Zaltrap (Colorectal Cancer) - Forecast and Market Analysis to 2023

Zaltrap (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Zaltrap (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Zaltrap (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China, Europe, United States, United Kingdom
TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023

TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “TS-1 (Colorectal Cancer) - Forecast and Market Analysis to ...

  • Industries : Pathology
  • Countries : Japan
Lonsurf (Colorectal Cancer) - Forecast and Market Analysis to 2023

Lonsurf (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Lonsurf (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Lonsurf (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : Japan, World, Spain, Italy, France, Germany, China, Europe, United States, United Kingdom
Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023

Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Cyramza (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Imprime PGG (Colorectal Cancer) - Forecast and Market Analysis to 2023

Imprime PGG (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Imprime PGG (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Imprime PGG (Colorectal Cancer) - Forecast and Market ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Europe, United States, United Kingdom
MGN1703 (Colorectal Cancer) - Forecast and Market Analysis to 2023

MGN1703 (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

MGN1703 (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “MGN1703 (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Europe, United Kingdom
Nintedanib (Colorectal Cancer) - Forecast and Market Analysis to 2023

Nintedanib (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Nintedanib (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Nintedanib (Colorectal Cancer) - Forecast and Market ...

  • Industries : Pathology
  • Countries : Japan, World, Spain, Italy, France, Germany, Europe, United States, United Kingdom
Diabetes, Metabolic Syndrome and Cardiovascular Disease

Diabetes, Metabolic Syndrome and Cardiovascular Disease

  • $ 3 400
  • Industry report
  • November 2014
  • by TriMark Publications

There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease--sometimes ...

  • Industries : Pathology
  • Countries : World, United States
Personalized Medicine Partnering Terms and Agreements

Personalized Medicine Partnering Terms and Agreements

  • $ 3 295
  • Industry report
  • November 2014
  • by Currentpartnering

Comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies. The Personalized Medicine Partnering ...

  • Industries : Therapy
Biologicals in Oncology Drug Pipeline Update 2015

Biologicals in Oncology Drug Pipeline Update 2015

  • $ 3 749
  • Industry report
  • January 2015
  • by Bioseeker

This drug pipeline update covers a wide array of biological drugs, such as: antibodies,proteins, peptides, DNA, RNA and cellular therapies. There are today 980 companies plus partners developing 1676 biological ...

  • Industries : Drug Discovery and Development
Biologicals in Oncology: Drug Pathway Analyzer 2015

Biologicals in Oncology: Drug Pathway Analyzer 2015

  • $ 3 675
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 1582 biological drugs known to affect more than 268 specific intracellular signaling pathways for the treatment ...

  • Industries : Drug Discovery and Development
Active Pharmaceutical Ingredients (API) Market in India 2015-2019

Active Pharmaceutical Ingredients (API) Market in India 2015-2019

  • $ 3 000
  • Industry report
  • January 2015
  • by Infiniti Research Limited

About Active Pharmaceutical Ingredients Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits ...

  • Industries : Drug and Medication
  • Countries : India
Global Ankylosing Spondylitis Market 2015-2019

Global Ankylosing Spondylitis Market 2015-2019

  • $ 3 000
  • Industry report
  • January 2015
  • by Infiniti Research Limited

About Ankylosing Spondylitis Ankylosing spondylitis is a subtype of spondylarthropathy. The primary symptoms of the disease are inflammatory spinal pain with subsequent limitation of spine mobility and ...

  • Industries : Pathology
  • Countries : World
Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain

Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain

  • $ 3 000
  • Industry report
  • January 2015
  • by MP Advisors

Pain is the leading cause of disability in the US, affecting more than cancer, diabetes and heart disease combined. Current analgesics for persistent pain are relatively ineffective, are associated with ...

  • Industries : Drug and Medication
  • Countries : United States, World
Hematological Malignancies: Multiple Myeloma (MM) - Early and Robust Diagnosis along with New Treatment Options can have Considerable Impact on Management of the Disease

Hematological Malignancies: Multiple Myeloma (MM) - Early and Robust Diagnosis along with New Treatment Options can have Considerable Impact on Management of the Disease

  • $ 3 000
  • Industry report
  • January 2015
  • by MP Advisors

While targeting unmet needs in the treatment of hematological malignancies/ cancer through innovative drug development strategies have witnessed favorable outcomes, the specific choice of the therapies ...

  • Industries : Pathology

About 500 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Pfizer Inc.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.